ArticleNeurogenetics2026
Homozygous NOTCH3 c.3373G > A (p.(Glu1125Lys)) in a consanguineous Chinese family presenting with vestibular migraine and epilepsy: Expanding the genotype-phenotype spectrum.
Article in Neurogenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Pathogenic variants in NOTCH3 are the main genetic cause of CADASIL, classically through disruption of cysteine residues within epidermal growth factor-like repeat (EGFr) domains. We report a consanguineous Han Chinese family in which two siblings carried a rare homozygous cysteine-sparing NOTCH3 variant (NM_000435.3: c.3373G > A; p.(Glu1125Lys)) presenting with vestibular migraine and epilepsy and severe cerebral small-vessel disease on neuroimaging. Both patients underwent detailed clinical assessment, including neurological examination and modified NINDS-CADASIL scoring. Brain magnetic resonance imaging (MRI) was obtained, and total cerebral microbleeds (CMBs) were quantified as counts/cm³ by two blinded neuroradiologists. Both siblings harbored the variant in a homozygous state within EGFr19 of NOTCH3. MRI showed confluent periventricular and temporal pole white matter hyperintensities (Fazekas grade 3) and numerous deep CMBs, particularly in the basal ganglia and cerebellum. Quantitatively, total CMB density was higher compared with controls (mean 2.15 counts/cm³ vs. 0.4 ± 0.2 counts/cm³; p = 0.008). This report expands the allelic and phenotypic spectrum of NOTCH3-related cerebral small-vessel disease and suggests that biallelic cysteine-sparing variants in EGFr19 may be associated with early-onset vestibular migraine, epilepsy, and a high CMB burden in the setting of consanguinity.Clinical trial registration: Not applicable.
Indexed as
Identifiers
41951984What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.